Substituted trifluoropropan-1-yl-imidazole alpha 2-receptor anagonists
US5173502A · kind A · utility
5Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 1991 |
| Grant date | Dec 22, 1992 |
| Priority date | — |
| Expiry date | Nov 1, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound selected from those of formula (I): ##STR1## in which R represents straight-chain or branched lower (C.sub.1 -C.sub.6) alkyl, (C.sub.3 -C.sub.8) cycloalkyl, optionally substituted phenyl, pyridyl or naphthyl, and PA1 R.sub.1 and R.sub.2, which are the same or different, each represents hydrogen, straight-chain or branched (C.sub.1 -C.sub.6) alkyl, or straight-chain or branched (C.sub.1 -C.sub.6) acyl, an enantiomer, diastereoisomer and epimer, and an addition salt thereof with a pharmaceutically-acceptable acid. Medicinal product, which is useful as .alpha..sub.2 -antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.